Try our Advanced Search for more refined results

London SPAC Axes 2 Deals For Biotech Firms Totaling £174M

By Dawood Fakhir ( January 24, 2024, 5:25 PM GMT) -- Blank-check company Ashington Innovation PLC said Wednesday that it has terminated a £135 million ($172 million) agreement to acquire biotechnology firm Cell Therapy Ltd., which trades as Celixir, due to uncertainty over required funds in current market conditions....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Related Sections

Law Firms

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!